ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 18 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Product Launch

Glenmark Pharmaceuticals Product Launch

Glenmark's US arm launched an authorized generic of INLYTA (axitinib) tablets. The product addresses a sizeable US market with established originator sales.

Source

NSE filing, NSE: GLENMARK. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Glenmark Pharmaceuticals Ltd: key numbers

Share price
₹2,615.80
Market cap
₹73,824 Cr
Revenue (annual)
₹16,983 Cr
Net profit (annual)
₹1,362 Cr
P/E (TTM)
50.9×Sector 48.6×
Promoter holding
46.65%+0.00% QoQ
FII holding
21.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Glenmark Pharmaceuticals Ltd

All →

Other product launch announcements

All →